Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-01-18
2011-01-18
Robinson, Hope A (Department: 1652)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007100, C530S350000
Reexamination Certificate
active
07871772
ABSTRACT:
Compositions and methods for the isolation and manipulation of misfolded, or partially misfolded, proteins present in blood and other biological materials are provided. In one aspect of the invention, the compositions, hereinafter termed “proteons” are comprised of misfolded proteins. Also provided are compositions and methods for the isolation and manipulation of proteon nucleation centers (PNCs) upon which the proteons of the present in blood and other biological materials form. In another aspect of the invention, the PNCs are comprised of metallic nanoclusters.
REFERENCES:
patent: 5143837 (1992-09-01), Soya et al.
patent: 5874238 (1999-02-01), Potempa et al.
patent: 6036774 (2000-03-01), Lieber et al.
patent: 7138255 (2006-11-01), Vodyanoy et al.
patent: 2007/0122799 (2007-05-01), Vodyanoy et al.
patent: 96/37282 (1996-11-01), None
patent: 9853849 (1998-12-01), None
patent: 02073210 (2002-09-01), None
patent: WO 02/073210 (2002-09-01), None
Shaked et al. Journal of Virology, vlo. 75, No. 17, pp. 7872-7874, 2001.
Lisiecki et al. Journal of Molecular Liquids, vol. 72, pp. 251-261, 1997.
Houston et al. The Lancet, vol. 356, pp. 999-1000, Sep. 16, 2000.
Aguzzi, A., “Prion diseases, blood and the immune system: concerns and reality”, Haematologica, 2000, vol. 85, No. 1, pp. 3-10.
Aguzzi, A., “Blood simle prion diagnostics”, Nature Medicine, 2001, vol. 7, No. 3, pp. 289-290.
Aiken III, J.D. and Finke, R.G., “A Review of Modern Transition-Metal Nanoclusters: Their Synthesis, Characterization, and Applications in Catalysis,” Journal of Molecular Catalysis A: Chemical, 1999, vol. 145, Elsevier Science B.V., pp. 1-44.
Attwood, T.K., “Metals in Prion Disease,” Trends in Biotechnology, 2002, vol. 20, No. 6, p. 235.
Binns, C. et al, “Synchrotron radiation studies of mass-selected Fe nanoclusters deposited in situ”, The European Physical Journal D, 2001, vol. 16, pp. 189-192.
Brown, Paul et al, “Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease”, J. Lab. Clin. Med., 2001, vol. 137, Mosby Inc., pp. 5-13.
Bush, A.I., “Metals and neuroscience”, Current Opinions in Chemical Biology, 2000, vol. 4, Elsevier Science Ltd., pp. 184-191.
Bush, A.I. et al, “Rapid Induction of Alzheimer A beta Amyloid Formation by Zinc”, Science, 1994, vol. 265, No. 5177, pp. 1464-1467/.
Bush, A.I., “Metal complexing agents as therapies for Alzheimer's disease”, Neurobiology of Aging, 2002, vol. 23, Elsevier Science Inc., pp. 1031-1038.
Campbell, A., et al, “Mechanisms by which metals promote events connected to neurodegenerative diseases”, Brain Resaerch Bulletin, 2001, vol. 55, No. 2, Elsevier Sceince Inc., pp. 125-132.
Carrell, R.W. and Lomas, D.A., “Conformational disease”, Lancet, 1997, vol. 350, pp. 134-138.
Gerner, C., “Biochemische Analyse endobiontischer Strukuren aus dem menschlichen Blut”, [Biochemical Analysis of Endobiontic Structures from Human Blood], Curriculum Oncologicum 01, Jan. 7, 2991, pp. 6-12.
Haritani M. et al, “Hydrated autoclave pretreatment enhancement of prion protein immunoreactivity in formalin-fixed bovine spongiform encephalopathy-affected brain”, Acta Neuropathol, 1994, vol. 87; pp. 86-90.
Harper, J.D. and Lansbury Jr., P.T., “Models of Amyloid Seeding in Alzheimer's Disease and Scrapie: Mechanistic Truths and Physiological Consequences of the Time-Dependent Solubility of Amyloid Proteins”, An.. Rev. Biochem., 1997, vol. 66, Annual Reviews Inc., pp. 385-407.
Krasemann, S. et al, Induction of antibodies against human prion proteins (PrP) by DNA-mediated immunization of PrP0/0 mice; Journal of Immunological Methods, 1996, vol. 199, pp. 109-118.
Lehmann, S., “Metal ionis and prion diseases”, Current Opinion in Chemical Biology, 2002, vol. 6, Elsevier Science Ltd., pp. 187-192.
Liu, C. and Xu, H., “The metal site as a template for the metalloprotein structure formation”, Journal of Inorganic Biochemistry, 2002, vol. 22, Elsevier Science B.V., pp. 77-86.
Makeig, S., “Response: Event-related brain dynamics-unifying brain electrophysiology”, Trends in Neuosciences, Aug. 2002, vol. 25, No. 8, pp. 390.
Otvos, J.D. et al, “Structure of the metal clusters in rabbit liver metallothionein”, Proc. Natl. Acad. Sci. USA; Dec. 1980, vol. 77, No. 18, pp. 7094-7098.
Rhoades, E. et al, “Aggregation of an amyloidogenic fragment of human islet amyloid polypeptide”, Biochimica et Biophysica Acta, 2000, vol. 1476, pp. 230-238.
Saborio G.P. et al, “Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding”, Nature, 2001, vol. 114, pp. 810-813.
Soto, C. et al, “Cyclic Amplification of Protein Misfolding: Application to Prion-Related Disorders and Beyond,” Trends in Neurosciences, 2002, vol. 25, No. 8, pp. 390-394.
Thackray, Alan M. et al, “Metal Imbalance and compromised antioxidant function are early changes in prior disease”, Biochem. J., 2002, vol. 362, pp. 253-258.
Watanabe, K. et al, “Inhibition against Heat Coagulation of Ovotransferrin by Ovalbumin Dry-Heated at 120 Degree C”, J. Agric. Food Chem., 2000, vol. 48, pp. 3965-3972.
Saborio Gabriela et al. (2001)“Sensitive Detection of Pathological Prion Protein by Cyclic Amplification of Protein Misfolding”Nature, Nature Publishing Group, London GB, vol. 411, No. 6839.
Rataboul et al. (2002)“Synthesis and Characterization of Monodisperse Zinc and Zinc Oxide Nanoparticles from the Organmetallic Precursor [Zn(C6H11)2]”Journal of Organometallic Chemistry, Elsevier-Sequoia S.A. Lausanne, CH, vol. 643-644.
Rivas et al. (1993) “First Steps Towards Tailoring Fine Andultrafine Iron Particles Using Microemulsions,”IEE Transactions on Magnetics, IEEE Service Center, New York, NY, US, vol. 29, No. 6.
Kapoor et al. (2000)“Laser-induced fragmentation and melting of cadmium and copper nanoparticles”Materials Research Bulletin, Elsevier, Kidlington, GB, vol. 35, No. 13.
(1997) “In-situ Observations of Classical Grain Growth Mechanisms During Sintering of Copper Nanoparticles on (001) Copper,”Applied Physics Letters, AIP, American Institute of Physics, Melville, NY, US, vol. 71, No. 12.
Enderlein, Gunther (Prof., Dr.), “Bacteria Cyclogeny”, pp. 27-39; published in German 1916, 1981 (translated Jan. 1999).
Ursini, Fulvio, et al, “Atherosclerosis: Another Protein Misfolding Disease?”, TRENDS in Molecular Medicine, vol. 8, No. 8, pp. 370-374, Aug. 2002.
Wetterberg, Lennart, et al “Micrometer-Sized Particles in Cerebrospinal Fluid (CSF) in Patients with Schizophrenia”, Neuroscience Letters, 329 (2002) pp. 91-95.
Schluter, Karen and Drenckhahn, Detlev, “Co-Clustering of Denatured Hemoglobin with Band 3: Its Role in Binding of Autoantibodies Against Band 3 to Abnormal and Aged Erythrocytes”, Medical Sciences, Proc. Natl. Acad. Sci. USA, vol. 83, pp. 6137-6141, Aug. 1986.
Prusiner, Stanley B., “Molecular Biology of Prion Diseases”, Science, vol. 252, Jun. 14, 1991, pp. 1515-1522.
Soto, Claudio, “Protein Misfolding and Disease; Protein Refolding and Therapy”, FEBS Letters, 498 (2001) pp. 204-207.
Wille, Holger, et al, “Structural Studies of the Scrapie Prion Protein by Electron Crystallography”, PNAS, vol. 99, No. 6, Mar. 19, 2002, pp. 3563-3568.
Geschwind, Michael D. (M.D., Ph.D.), et al, “Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease”, Arch Neurol, vol. 60, Jun. 2003, pp. 813-816.
Kannan, Rama, et al, “Isolation and Characterization of the Hemichrome-Stabilized Membrane Protein Aggregates from Sickle Erythrocytes”, The Journal of Biological Chemistry, vol. 263, No. 27, Issue of Sep. 25, 1988, pp. 13766-13773
Pustovyy Oleg M.
Samoylov Alexandre M.
Vodyanoy Vitaly J.
Andrus Sceales Starke & Sawall LLP
Auburn University
Robinson Hope A
LandOfFree
Methods for detecting misfolded proteins in biological samples does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for detecting misfolded proteins in biological samples, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting misfolded proteins in biological samples will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2721129